Healthcare -
Biotechnology - NASDAQ - US
$ 38.6444
-0.118 %
$ 10.8 B
Market Cap
21.96
P/E
EXEL - REVENUE
Revenue EXEL - Exelixis, Inc.
2.17 B
LAST VALUE
16.02%
2 YEAR CAGR
17.51%
5 YEAR CAGR
56.18%
10 YEAR CAGR